Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Bolós

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 22, 2009
Notch signalling in cancer stem cellsV Bolós, M Blanco, V Medina, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 19, 2009
Biology of BMP signalling and cancerM Blanco Calvo, V Bolós Fernández, V Medina Villaamil, et al.
Neoplasia (New York, N.Y.)|January 12, 2013
MicroRNA expression profiling of peripheral blood samples predicts resistance to first-line sunitinib in advanced renal cell carcinoma patientsAngelo Gámez-Pozo, Luis M Antón-Aparicio, Cristina Bayona, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 22, 2009
Notch signalling in cancer stem cellsV Bolós, M Blanco, V Medina, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 19, 2009
Biology of BMP signalling and cancerM Blanco Calvo, V Bolós Fernández, V Medina Villaamil, et al.
Neoplasia (New York, N.Y.)|January 12, 2013
MicroRNA expression profiling of peripheral blood samples predicts resistance to first-line sunitinib in advanced renal cell carcinoma patientsAngelo Gámez-Pozo, Luis M Antón-Aparicio, Cristina Bayona, et al.
Pageof 1